RT @RevistaMFSamfyc: Complicaciones relacionadas con la diabetes y mortalidad en pacientes con fibrilación auricular que toman diferentes a…
Complicaciones relacionadas con la diabetes y mortalidad en pacientes con fibrilación auricular que toman diferentes anticoagulantes orales: análisis nacional https://t.co/qmccBXtKLT PMID 35157495
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
Muy similar en el resto del mundo
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
RT @Felipediezhoyo: ✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM)…
✅Otro estudio con ⬇️mortalidad (☠️) ACOD vs antagonistas de la vitK (y ⤵️ complicaciones macro y microvasculares de DM). Pero seguimos sin poder poner ACOD de inicio en FA en nuestros pacientes (en Madrid al menos; supongo que "similar" en resto 🇪🇸) https:
RT @LuisZuritaG: Anticoagulantes no Vit. K se asocian con menor complicación macrovascular, microvascular, diálisis en DIABETES, comparados…
Anticoagulantes no Vit. K se asocian con menor complicación macrovascular, microvascular, diálisis en DIABETES, comparados con warfarina.#diabetes
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/DkZlAiSVJQ
RT @Manugrillo2: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants:…
RT @Manugrillo2: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants:…
RT @Manugrillo2: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants:…
RT @Manugrillo2: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants:…
RT @Manugrillo2: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants:…
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/0uvD54Pygq
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/XDxnxFWnQL
RT @dr_guevara: #Diabetes -Related Complications and Mortality in patients with #AFib receiving VKAs vs DOACs https://t.co/RxTabl8Cqe via…
RT @dr_guevara: #Diabetes -Related Complications and Mortality in patients with #AFib receiving VKAs vs DOACs https://t.co/RxTabl8Cqe via…
RT @dr_guevara: #Diabetes -Related Complications and Mortality in patients with #AFib receiving VKAs vs DOACs https://t.co/RxTabl8Cqe via…
#Diabetes -Related Complications and Mortality in patients with #AFib receiving VKAs vs DOACs https://t.co/RxTabl8Cqe via @practiceupdate @AnnalsofIM @FormigaFrancesc @MjoseBarahona1 @veronikpk @macesari @MiguelCamafort @IcyfaSemi @radcliffeCARDIO @Bona
Los DOACs se asocian con menores riesgos de complicaciones diabéticas y mortalidad que la warfarina en pacientes con FA y DM Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants https://t
RT @FormigaFrancesc: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagula…
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoag… https://t.co/PcFEayS65T
RT @AnnalsofIM: #ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of dia…
RT @AnnalsofIM: #ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of dia…
RT @AnnalsofIM: #ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of dia…
RT @AnnalsofIM: #ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of dia…
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis https://t.co/isTbKLy7by https://t.co/KMNJ9oqvbp
RT @AnnalsofIM: #ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of dia…
#ICYMI, a new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes complications and mortality than warfarin: https://t.co/wQgfDW4TVQ https://t.co/822998zSWp
心房細動と糖尿病を合併している患者においてDOACはワルファリンと比較して大血管合併症、微小血管合併症、血糖緊急、死亡率のハザード減少と関連した。Ann Intern Med. 2022. PMID: 35157495. https://t.co/BPwdefVOz8
Los pacientes con diabetes y fibrilación auricular pueden obtener más beneficios de los anticoagulantes orales no-vitamina K Vs warfarina, sugiere un nuevo estudio. https://t.co/uFXs34nkGH
RT @mbotana: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A N…
RT @AnnalsofIM: This week, A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of…
RT @AnnalsofIM: This week, A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of…
RT @AnnalsofIM: This week, A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of…
This week, A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes complications and mortality than warfarin: https://t.co/EwnSEn2HFt https://t.co/8Mzs7etP2u
In this retrospective cohort study of patients in Taiwan's national health insurance database, DOACs were associated with lower hazards of diabetic complications and mortality than warfarin in patients with AF and diabetes. https://t.co/hgIgUaJSlC
(Ann Intern Med) Complicaciones y mortalidad por diabetes en pac con FA anticogulados anticoagulantes https://t.co/m84uo7LwJd Est Observ #DM2 #ACOD https://t.co/N7FEO2fnSr
Use of newer oral anticoagulants offer greater benefits to patient with #diabetes,beyond #stroke prevention, compared to the older & cheaper warfarin. ⬇️Micro, macrovascular complications & death @AnnalsofIM @docanoopmisra @EASDelearning @TakShubh
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/M7mSAwR1Nz @mencardio @torresviera @jjamaro @DrPontecarl
RT @FormigaFrancesc: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagula…
RT @AnnalsofIM: A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes co…
Evidence about the association between types of oral anticoagulants and hazards of diabetes complications is limited in patients with atrial fibrillation (AF) and diabetes mellitus (DM). Read more: https://t.co/P4b3fzEW4E https://t.co/boZkNxDrVJ
RT @AnnalsofIM: A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes co…
RT @AnnalsofIM: A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes co…
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/b8S72U6HGW
RT @AnnalsofIM: A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes co…
RT @AnnalsofIM: A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes co…
A new study of patients with #afib and #diabetes found that the use of NOAC was associated with a lower risk of diabetes complications and mortality than warfarin: https://t.co/wQgfDW4TVQ https://t.co/1G2t8euR97
RT @FormigaFrancesc: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagula…
RT @FormigaFrancesc: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagula…
Anticoagulantes orales directos se asocian con menor riesgo de complicaciones que la warfarina en pacientes con fibrilación auricular y diabetes https://t.co/7EqICeCWYV
RT @FormigaFrancesc: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagula…
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/f2bJWazp1L @chemachir @dr_guevara @BonanadClara @IcyfaSe
RT @DrAlenazi: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A…
T1DM on rivaroxaban - where am I fitting in here😅 Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants: A Nationwide Analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/2xhXu